The Alliance of Community Health Plans (ACHP) submitted a response to an RFI from Senator Bill Cassidy (R-LA), Ranking Member of the Senate HELP Committee, on access to cell and gene therapies. ACHP highlights current limitations in the health care system and urges policymakers to consider the underlying prices of these drugs, differences in coverage and the need for coordination and collaboration.
New from ACHP:
- ACHP Statement on Drug Pricing
- Ending the Allure of Drug Advertising
- ACHP Letter to Dr. Oz on Deregulation in Health Insurance
- ACHP Comments on CMS Marketplace Integrity & Affordability Proposed Rule
- ACHP Statement on CY2026 MA and Part D Rate Notice
- ACHP Statement on Final CY2026 MA and Part D Rule
